| Chemicals Industry | Materials Sector | Dr. Ilham Kadri Ph.D. CEO | XFRA Exchange | - ISIN |
| Belgium Country | 12,686 Employees | - Last Dividend | - Last Split | - IPO Date |
Syneos Health, Inc. stands as a cornerstone in the biopharmaceutical industry, offering an integrated suite of solutions critical for advancing clinical development. This organization is instrumental in facilitating the pharmaceutical field's drive towards innovation by expediting the drug development process, thus enabling quicker access to new therapies. By fostering strategic partnerships and upholding a commitment to scientific excellence, Syneos Health plays an indispensable role in improving global health outcomes and reinforcing the biopharmaceutical supply chain. Through its full-spectrum services, the company significantly affects the development of novel treatments, simultaneously enhancing project efficiency and ensuring adherence to regulatory standards.
Syneos Health, Inc. provides a diverse array of services aimed at supporting the pharmaceutical industry at various stages of the drug development pipeline. Each service is designed to streamline the process, making innovations more accessible and efficient.